[CONC Membership Roster] [CONC Meeting Rosters]

The Clinical Oncology Study Section reviews applications in the areas of clinical patient-oriented research and clinical therapeutic trials.  This includes clinical trials with therapeutic intent using drugs, radiation, surgery, and/or biological agents. Specific areas covered by CONC:

• Clinical therapy trials including surgical intervention, chemotherapy, radiation therapy and radiopharmaceuticals, combined modality therapy, immunotherapy (antibody and cellular), vaccine and gene therapy, and therapy with biological response modifiers.
• Pharmacologic and toxicologic studies of new modalities in patients and correlative studies relevant to therapeutic clinical trials.
• Non-behavioral alternative cancer therapies and trials.
• Research on the treatment of cancer therapy-related nausea and vomiting, pain, mucositis, alopecia and fatigue.
• Age-specific issues including: changes in tumor behavior with aging, clinical and laboratory assessment of the older cancer patient, age-related factors that withstand effective cancer treatment, coordination of care of the older cancer patient, pharmacology of chemotherapy agents, and amelioration of toxicity

The study sections with most closely related areas of similar science listed in rank order are:

Developmental Therapeutics Study Section [DT] 
Cancer Immunopathology and Immunotherapy Study Section [CII] 
Cancer Biomarkers Study Section [CBSS] 
Transplantation, Tolerance and Tumor Immunology Study Section [TTT] 
Medical Imaging [MEDI] 
Aging Systems and Geriatrics Study Section [ASG]